By the end of April, Medtronic plans to close more than five manufacturing sites and six distribution centers as part of restructuring efforts to improve the company's profit margin.
Medtronic — based in Ireland, but run from Fridley — also is tightening its supplier network, CEO Geoff Martha said Monday at the J.P. Morgan Healthcare Conference in San Francisco. The company has ceased business with more than 200 suppliers.
The company refused to disclose which manufacturing locations will be affected; the company on its website said it has 78 plants globally. Martha said the six distribution centers will be consolidated into two other locations that will become megacenters. Medtronic also declined to say where those larger centers would be located.
"We have no specifics to share right now," said spokeswoman Erika Winkels. "Consistent with operations best practices, we are always evaluating our manufacturing and distribution footprint for efficiencies that improve our performance."
Winkels also did not comment on the number of jobs affected by the shutdowns.
During the presentation, Medtronic Chief Financial Officer Karen Parkhill said the company is "managing within the headcount that we've got."
Martha said that the moves, focused on its global operations and supply chain, are aimed to drive the "largest near-term savings" for the company.
Martha said the company has been evaluating every aspect of the supply chain over the past few years. He said progress is trackable, but inflation and other factors have meant the company has not yet widened profit margins.